|Articles|July 13, 2022
Data Integrity: an alternative approach to eliminate blind spots
Author(s)Telstar
This article presents a detailed mapping of processes and data flow to identify the gaps associated to Data Integrity for GxP processes managed by computerized system and/or manually.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
FDA Deploys Agentic AI Capabilities for Agency Staff
2
Why Pharma’s AI Agents Need Smaller, Domain-Specific Models First
3
Immortal Dragons Will Help Etheros Target Aging and Related Diseases
4
BirchBioMed’s Idiopathic Pulmonary Fibrosis Treatment Receives Orphan Drug Designation
5
